TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 1 | 0 | 5 | 7 | -12 | -17 | -46 | -13 |
S | %wins | 100 | 0 | 0 | 100 | 100 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/28/15 17:20 | 9/25/15 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Arnold Charlotte C. | MN | O | VP,CFO | M.d | 145 | 7.61 | 19 | 19 | 61 | 50 | D | 367 | 54 | -30 | -31 | -21 | -17 | -20 | -7 | -6 | 9 | 4 | 18 | -17 | 59 |
9/3/15 16:30 | 9/2/15 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Arnold Charlotte C. | MN | O | VP,CFO | M.d | 69 | 33.00 | 14 | 2 | 7 | 31 | D | 637 | 84 | -22 | -5 | -26 | -8 | 7 | -1 | 0 | 0 | -16 | -16 | -32 | 19 |
5/7/15 17:05 | 5/6/15 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Arnold Charlotte C. | MN | O | VP,CFO | M.d | 25 | 6.36 | 16 | 4 | 16 | 30 | D | 632 | 67 | 27 | -6 | -13 | -24 | -21 | -17 | 0 | -3 | 4 | 12 | -25 | -12 |
3/16/15 17:45 | 3/12/15 | ANIP | Ani Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Arnold Charlotte C. | MN | O | VP,CFO | S | -2,835 | 63.00 | 27 | -45 | -68 | 21 | D | 673 | 93 | 118 | 17 | 8 | -13 | -10 | -5 | 0 | 5 | 7 | -12 | -17 | -46 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |